These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38486204)

  • 21. The AMORE protocol as salvage treatment for non-orbital head and neck rhabdomyosarcoma in children.
    Buwalda J; Blank LE; Schouwenburg PF; Copper MP; Strackee SD; Voûte PA; Merks JH; Caron HN
    Eur J Surg Oncol; 2004 Oct; 30(8):884-92. PubMed ID: 15336736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics and long-term outcomes of rhabdomyosarcoma in Korean children, adolescents and young adults: a single-center experience.
    Park M; Lee JA; Jin HY; Kim JY; Park JW; Kim JH; Kang HG; Park SY; Park EY; Park HJ; Park BK
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3109-3119. PubMed ID: 35870013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
    Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Parameningeal or non-parameningeal head and neck rhabdomyosarcoma: a study based on propensity score matching and survival analysis].
    Tao YJ; Zhen HN; Guan H; Shen J; Zhang FQ; Liu ZK
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec; 57(12):1409-1417. PubMed ID: 36707944
    [No Abstract]   [Full Text] [Related]  

  • 25. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
    Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma.
    Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):718-725. PubMed ID: 33516439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The survival benefit of radiotherapy in localized primary adult rhabdomyosarcoma.
    Zhao R; Yu X; Feng Y; Wang J; Chen Y; Mao Y; Yin W; Zhang Z; Guo X; Ma S
    Asia Pac J Clin Oncol; 2020 Aug; 16(4):266-272. PubMed ID: 32285607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-inferior efficacy of non-surgical treatment to surgical treatment in patients with nonmetastatic head and neck rhabdomyosarcoma: a SEER-based study.
    Liang W; Li L; Wang M; Liu Y; Qiu Y; Zhang B; Wu Q; Wei Y
    Clin Transl Oncol; 2023 Jun; 25(6):1779-1792. PubMed ID: 36640207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution.
    Frata P; Buglione M; Grisanti S; Bonetti B; Vitali E; De Stefani A; Magri E; Peveri A; Marini G; Rossi G; Magrini SM
    Tumori; 2005; 91(6):456-62. PubMed ID: 16457141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete second look operation and radiotherapy in locally advanced non-alveolar rhabdomyosarcoma in children: A report from the AIEOP soft tissue sarcoma committee.
    Cecchetto G; Carretto E; Bisogno G; Dall'Igna P; Ferrari A; Scarzello G; Donfrancesco A; Alaggio R; Indolfi P; Carli M
    Pediatr Blood Cancer; 2008 Nov; 51(5):593-7. PubMed ID: 18668515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of failure after induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma: the Queen Mary Hospital experience.
    Chua DT; Sham JS; Choy D; Kwong DL; Au GK; Kwong PW; Yau CC; Cheng AC; Wan KY
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1219-28. PubMed ID: 11286826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term results in children with head and neck rhabdomyosarcoma: A report from the Italian Soft Tissue Sarcoma Committee.
    Affinita MC; Ferrari A; Milano GM; Scarzello G; De Leonardis F; Coccoli L; Pericoli R; Basso E; Zanetti I; Scagnellato A; Bisogno G
    Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy and prognostic significance of regional lymph node involvement in embryonal rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study Group.
    Ben-Arush M; Minard-Colin V; Scarzello G; Fajardo RD; Terwisscha Van Scheltinga S; Bernier V; Jenney M; Gallego S; Zanetti I; Cesen M; Merks JHM; Bisogno G
    Eur J Cancer; 2022 Sep; 172():119-129. PubMed ID: 35763871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Head and neck rhabdomyosarcoma in adults.
    Wu Y; Li C; Zhong Y; Guo W; Ren G
    J Craniofac Surg; 2014 May; 25(3):922-5. PubMed ID: 24777012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcoma.
    Wolden SL; La TH; LaQuaglia MP; Meyers PA; Kraus DH; Wexler LH
    Cancer; 2003 Jan; 97(1):179-85. PubMed ID: 12491519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of Radiotherapy Use and Outcomes in Head and Neck Soft-Tissue Sarcoma in a National Cohort.
    Kim JK; Verma N; McBride S; Riaz N; Boyle JO; Spielsinger D; Sabol C; Waldenberg T; Brinkman T; Alektiar K; Lee NY; Tsai CJ
    Laryngoscope; 2020 Jan; 130(1):120-127. PubMed ID: 30892716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV.
    Pappo AS; Meza JL; Donaldson SS; Wharam MD; Wiener ES; Qualman SJ; Maurer HM; Crist WM
    J Clin Oncol; 2003 Feb; 21(4):638-45. PubMed ID: 12586800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans-Atlantic, multicenter cross-sectional cohort study.
    Hol MLF; Indelicato DJ; Slater O; Kolb F; Hewitt RJ; Ong J; Becking AG; Gains J; Bradley J; Sandler E; Gaze MN; Pieters B; Mandeville H; Fajardo RD; Schoot R; Merks JHM; Hammond P; Smeele LE; Suttie M
    Pediatr Blood Cancer; 2023 Aug; 70(8):e30412. PubMed ID: 37249325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rhabdomyosarcoma of the head and neck region: experience at the pediatric unit of the Istituto Nazionale Tumori, Milan.
    Meazza C; Ferrari A; Casanova M; Massimino M; Luksch R; Spreafico F; Cefalo G; Terenziani M; Polastri D; Podda M; Catania S; Cereda S; Gandola L; Fossati-Bellani F; Cantù G
    J Otolaryngol; 2006 Feb; 35(1):53-9. PubMed ID: 16527019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Worse Outcomes for Head and Neck Rhabdomyosarcoma Secondary to Reduced-Dose Cyclophosphamide.
    Casey DL; Wexler LH; Wolden SL
    Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1151-1157. PubMed ID: 30508617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.